Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Implantable medical device maker Cyberonics (CYBX) said fiscal Q3 earnings per share rose 9% compared to a year ago, to 51 cents, beating analyst estimates by 2 cents. Revenue also rose 9% to $68.2 mil, just missing views for $69.7 mil. The company cited weather-induced delays in operating room schedules, positioning of holidays in the quarter and "greater-than-normal turbulence in health insurance markets" for the weaker-than-expected revenue. During the quarter the company's international sales rose to a record $15.2 mil. Shares fell 4.3% to 69.36.